中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
合肥物质科学研究院 [6]
数学与系统科学研究院 [1]
上海营养与健康研究所 [1]
兰州化学物理研究所 [1]
采集方式
OAI收割 [9]
内容类型
期刊论文 [9]
发表日期
2024 [1]
2022 [3]
2021 [2]
2020 [1]
2017 [1]
2016 [1]
更多
学科主题
Biochemist... [1]
Genetics &... [1]
筛选
浏览/检索结果:
共9条,第1-9条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
The effect of thickener structure degradation on tribological properties: Study on the decay mechanism of polyurea grease under mechanical-thermal aging conditions
期刊论文
OAI收割
Tribology International, 2024, 期号: 194, 页码: 109576
作者:
Guangrong Sha
;
Rui Yu
;
Bingbing Lai
;
Yiping Sun
;
Wenjing Lou
  |  
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2024/12/20
Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial
期刊论文
OAI收割
BMC MEDICINE, 2022, 卷号: 20
作者:
Song, Zhengbo
;
Lou, Guangyuan
;
Wang, Yina
;
Yang, Zhiping
;
Wang, Wenxian
  |  
收藏
  |  
浏览/下载:50/0
  |  
提交时间:2022/12/23
Thymic epithelial tumors
Apatinib
Efficacy
Toxicities
Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study
期刊论文
OAI收割
BMC PULMONARY MEDICINE, 2022, 卷号: 22
作者:
Wang, Wenxian
;
Shao, Lan
;
Xu, Yibing
;
Song, Zhengbo
;
Lou, Guangyuan
  |  
收藏
  |  
浏览/下载:46/0
  |  
提交时间:2022/12/23
Non-small cell lung cancer
Prognosis
Angiogenesis
Tyrosine kinase inhibitors
Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report
期刊论文
OAI收割
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 卷号: 11
作者:
Gu, Xiaodong
;
Wang, Wenxian
;
Wu, Wei
;
Zhang, Yiping
;
Shao, Lan
  |  
收藏
  |  
浏览/下载:124/0
  |  
提交时间:2022/12/22
Non-small cell lung cancer (NSCLC)
HIVEP1-ALK
alectinib
intergenic region (IGR)
case report
The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study
期刊论文
OAI收割
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
作者:
Wang, Wenxian
;
Gu, Xiaodong
;
Wang, Liping
;
Pu, Xingxiang
;
Feng, Huijing
  |  
收藏
  |  
浏览/下载:79/0
  |  
提交时间:2022/01/10
Non-small cell lung cancer
PD-L1
Immune checkpoint inhibitor
Immune-related adverse event
Expert consensus on thermal ablation therapy of pulmonary subsolid nodules (2021 Edition)
期刊论文
OAI收割
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 卷号: 17
作者:
Ye, Xin
;
Fan, Weijun
;
Wang, Zhongmin
;
Wang, Junjie
;
Wang, Hui
  |  
收藏
  |  
浏览/下载:74/0
  |  
提交时间:2022/03/21
Ground-glass nodule
lung cancer screening
pulmonary subsolid nodules
thermal ablation
Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer
期刊论文
OAI收割
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:
Wang, Wenxian
;
Huang, Zhangzhou
;
Yu, Zongyang
;
Zhuang, Wu
;
Zheng, Weijun
  |  
收藏
  |  
浏览/下载:40/0
  |  
提交时间:2020/11/30
immune checkpoint inhibitor
non-small cell lung cancer
biomarker
chemotherapy
lung immune prognostic index
CNVbase: Batch identification of novel and rare copy number variations based on multi-ethnic population data
期刊论文
OAI收割
JOURNAL OF GENETICS AND GENOMICS, 2017, 卷号: 44, 期号: 7, 页码: 367-370
作者:
Zhang, Cheng
;
Lu, Jianqi
;
Du, Renqian
;
Zhang, Feng
;
Jin, Li
  |  
收藏
  |  
浏览/下载:36/0
  |  
提交时间:2020/12/09
beta-glucan
Muscle
C2C12
Diversification and Corporate Performance: Evidence from China's Listed Energy Companies
期刊论文
OAI收割
SUSTAINABILITY, 2016, 卷号: 8, 期号: 10, 页码: 17
作者:
Li, Qiming
;
Wang, Wenhuan
;
Lou, Yiping
;
Cheng, Ke
;
Yang, Xiaoguang
  |  
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2018/07/30
industrial diversification
international diversification
corporate performance
sustainable development
China